|
|
 |
ADVAIR HFA Drug Profile, 2024 |
$399.00 |
|
$798.00 |
|
|
 |
ALECENSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANORO ELLIPTA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ASCORBIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
APLENZIN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACETYLTRIBUTYL CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|